ERNDIMQA - Congenital Disorders of Glycosylation

Purpose: Qualitative interpretation of sialotransferrin profiles in the screening for Congenital Disorders of Gycosylation (CDG)
Scientific Expert: Dr. D.J. Lefeber e-mail:
Scheme Organiser: Dr. E. van der Hagen e-mail:
CSCQ: Dr. Xavier Albe,
Analytes: Sialotransferrin isoforms
Number of Specimens/Year: 6
Matrix of the Specimens: Lyophilised human plasma/serum
Volume/Specimen: 25 microL
Number of Shipments/Year: One shipment of 6 samples
Submission of Results: Via ERNDIM-CSCQ website
Reports: Via ERNDIM-CSCQ website
Certificate: Once a year issued by ERNDIM Board
Number of Participants: 66 (2019)
Status of the Scheme: Pilot since 2008, official in 2010
Geographic Area: Worldwide
Limitation Participation: None
Cost/Year: 363 EURO (2021)
How to subscribe: e-mail:
  Click here for Annual Reports